Q-linea announces strong support of the TO1 warrant program as well as an extension of existing loan from large shareholder
Q-linea announces strong support of the TO1 warrant program as well as an extension of existing loan from large shareholder
Q-linea AB (publ) (“Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) today announces that holders representing approximately 61 percent of the total number of outstanding warrants have expressed their support and intention to exercise all of their warrants during the TO1 exercise period.
Shareholders including Ulf Landegren (Landegren Gene Technology AB), Investment AB Öresund, Transferator AB and Fjärde AP-fonden, representing approximately 61 percent of the outstanding warrants, have expressed their intention to exercise all of their TO1 warrants during the exercise period 5 – 19 May 2025.
Q-linea and Nexttobe AB has also agreed to extend the existing loan of SEK 40.5 million with one year to 30 June 2027. The extension will be addressed at the upcoming annual general meeting, scheduled to be held on June 26 2025.
“We are pleased to see the continued strong support from our main owners as we continue our journey towards profitability” said Stuart Gander, President and CEO of Q-linea.